Preventing and treating infections in children with asplenia or hyposplenia

Paediatrics and Child Health (Canada)

Volumn 19, Issue 5, 2014, Pages 271-274

  Salvadori, Marina I ^a   Price, Victoria E ^a  

^a CANADIAN PAEDIATRIC SOCIETY   (Canada)

Author keywords

Antibiotic prophylaxis; Immunization; Sepsis; Splenectomy

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; VACCINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ASPLENIA; BACTERIAL INFECTION; EMERGENCY WARD; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HYPOSPLENISM; IMMUNIZATION; INFLUENZA; MALARIA CONTROL; NEISSERIA MENINGITIDIS; PATIENT EDUCATION; SEPSIS; SHORT SURVEY; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE;

EID: 84900384856     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/19.5.271     Document Type: Short Survey

References (13)

1. Singer DB. Postsplenectomy sepsis. Perspect Pediatr Pathol 1973;1:285-311.
2. Holdwoth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: Actual versus perceived risks. Br J Surg 1991;78(9):1031-8.
3. Price VE, Blanchette VS, Ford-Jones EL. The prevention and management of infections in children with asplenia or hyposplenia. Infect Dis Clin North Am 2007;21(3):697-710, viii-ix.
4. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001;43(3):182-6.
5. Waldman JD, Rosenthal A, Smith AL, Shurin S, Nadas AS. Sepsis and congenital asplenia. J Pediatr 1977;90(4):555-9.
6. Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in humans: Review of the literature and cases report. Eur J Epidemiol 1996;12(5):521-33.
7. Davies JM, Barnes R, Milligan D; British Committee for Standards in Haematology, Working Party of the Haematology/Oncology Task Force. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2002;2(5):440-3.
8. Krause PJ, Gewurz BE, Hill D, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis 2008;46(3):370-6.
9. O'Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: Is hyporesponsiveness an issue? Lancet Infect Dis 2007;7(9):597-606.
10. Shatz DV, Schinsky MF, Pais LB, Romero-Steiner S, Kirton OC, Carlone GM. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998;44(5):760-5.
11. American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases, 29th edn. Elk Grove Village, IL: AAP, 2012.
12. Bach O, Baier M, Pullwitt A, et al. Falciparum malaria after splenectomy: A prospective controlled study of 33 previously splenectomized Malawian adults. Trans R Soc Trop Med Hyg 2005;99(11):861-7.
13. Public Health Agency of Canada. Canadian recommendations for the prevention and treatment of malaria among international travellers - 2009: Supplement. Can Commun Dis Rep 2009;35-S1:1-8: http://www.phac-aspc.gc.ca/ publicat/ccdr-rmtc/09vol35/35s1/index-eng.php (Accessed February 19, 2014).